// company-profile

Kymera Therapeutics, Inc.

KYMRExchange: NasdaqSector: Biological Products, (No Diagnostic Substances)Inc.: DEFilings: 104Insiders: 38

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 14 insiders purchased shares versus 11 sales. Buying was led by Booth Bruce.

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Apr 29, 2026Mainolfi NelloKYMRSale936$82.45$77K
Apr 29, 2026Mainolfi NelloKYMROption Exercise30,000$2.08$62K
Apr 29, 2026Mainolfi NelloKYMRSale12,059$81.70$985K
Apr 29, 2026Mainolfi NelloKYMROption Exercise30,000$0.00$0K
Apr 29, 2026Mainolfi NelloKYMRSale17,005$80.74$1.37M

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →